Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
about
Theranostic Biomarkers for SchizophreniaPharmacogenetics of antipsychotics.Clinical significance of pharmacogenomic studies in tardive dyskinesia associated with patients with psychiatric disordersAntipsychotic-induced movement disorders in long-stay psychiatric patients and 45 tag SNPs in 7 candidate genes: a prospective studyPharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionThe promise and reality of pharmacogenetics in psychiatryAssociation study indicates a protective role of phosphatidylinositol-4-phosphate-5-kinase against tardive dyskinesia.Ethical and Policy Considerations in the Application of Pharmacogenomic Testing for Tardive Dyskinesia: Case Study of the Dopamine D3 Receptor.Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations.Tardive dyskinesia and withdrawal emergent syndrome in children.Pharmacogenetics of drug-induced birth defects: what is known so far?Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.Pharmacogenetics of tardive dyskinesia: an updated review of the literature.Do tardive dyskinesia and L-dopa induced dyskinesia share common genetic risk factors? An exploratory study.No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia.CYP1A2 and CYP2D6 Gene Polymorphisms in Schizophrenic Patients with Neuroleptic Drug-Induced Side Effects.Cytochrome P450 1A2 co-determines neuroleptic load and may diminish tardive dyskinesia by increased inducibility.Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.
P2860
Q33624412-6D3F533A-314A-4CAD-BAFD-C2FECAAAD024Q33836837-F4EB9E07-131F-45C4-A977-05724C32BBECQ34391577-692A7D45-6A02-4366-A208-0FE3D99A39D3Q34506671-91202800-E9A3-429A-A475-CB71AB2344DFQ34676533-57851A26-FFBA-40D7-9DCE-FD971DECAFBEQ35226451-9FA2EE2F-9B99-4798-A381-0FC89F776D05Q35626932-C1C59E1B-41B5-4CE5-AB8A-BDD80D8D884BQ35693061-180285C1-0CA2-40FB-9318-C6F117C5AA5BQ36806137-F609A9EA-1956-44C5-A3F2-DCA098B43293Q37762257-AD54B791-B64F-46B2-BB83-EECEC990CC0FQ37869124-8BBB7C3A-1C13-4C75-B5B7-4AB85CB62384Q38154911-864AEC04-4440-441F-98AB-52A74B6A612EQ38657158-3FE43EEC-EDCB-4E4E-8CF4-0852FD09ACF6Q38911685-D7EDFFA9-741C-42CB-85C9-E9D5D29DEA66Q45007058-60E26CDE-589E-4762-B245-E712668C2002Q45232895-62DEA1A6-421F-4CB6-8E9B-4303428D37E8Q50535669-4088820A-F919-4EA8-BD22-DD4C2A1A812EQ50600844-6BD156F9-DB14-4943-81B6-F0F14A76F964Q50794479-FE3B09DC-7CBD-46B1-BA41-927CC222FA03
P2860
Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@en
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@nl
type
label
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@en
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@nl
prefLabel
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@en
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@nl
P2093
P50
P1476
Tardive dyskinesia and DRD3, H ...... atric inpatients from Siberia.
@en
P2093
A F Y Al Hadithy
A J M Loonen
B Wilffert
J R B J Brouwers
L Ryadovaya
O Fedorenko
P Pechlivanoglou
P304
P356
10.1016/J.PNPBP.2009.01.010
P577
2009-01-24T00:00:00Z